Transforming Oncology Patient Care
Innovative Approach to Structured Routine Reporting with mint Lesion at the University Hospital Zurich Heidelberg, DE, 05/09/2023 - Mint Medical GmbH and the University Hospital Zurich (USZ) will…
Almost done
Almost done Thank you for your interest in our newsletter. In a few minutes you will receive a confirmation e-mail. Follow the link you receive in it to complete the registration. If the e-mail is…
Career
Career If you have any questions before applying, please e-mail them to recruiting.services @ brainlab.com Cannot find a suitable vacancy? We are always interested in meeting new talents to…
University Hospital Jena: Research Investigating the Viability of Accelerating Whole-Body MRI in Children and Adolescents through STIR DWI with Simultaneous Multi-Slice Excitation
This study[1] addressed the challenges of conducting WB-MRI in paediatric patients, particularly the prolonged acquisition time required for diffusion-weighted imaging (DWI), which is a crucial…
WUSTL: Discrepant Assessments of Progressive Disease in Clinical Trials between Routine Clinical Reads and Formal RECIST 1.1 Interpretations
In this retrospective study utilizing the mint Lesion™ software[1], researchers found that routine clinical interpretations frequently resulted in the overdiagnosis of progressive disease compared…
Early lung cancer detection through LDCT screening as a potential way to improve patient outcomes in Germany
The establishment of a nation-wide lung cancer screening program in Germany has been a subject of considerable interest and debate among healthcare professionals, researchers, and policymakers for…
RACOON FHIR Workshop: Empowering Healthcare Research via Enhanced Interoperability
This week Brainlab hosted the RACOON FHIR Workshop with around 40 participants. The workshop was organized by Mint Medical and supported by Snke OS, with the primary goal of training computer…
Tumor Growth Rate Modeling: A Novel Approach to Evaluating the Efficacy of Cancer Therapies
The 2020 review of Clinical Trial Evidence Supporting US Food and Drug Administrative Approval of Novel Cancer Therapies Between 2000 and 2016 revealed that although novel cancer therapies showed…
